Published in Proc Natl Acad Sci U S A on November 25, 2008
Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med (2010) 2.61
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest (2010) 2.00
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proc Natl Acad Sci U S A (2013) 1.38
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts. Blood (2009) 1.15
Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood (2010) 1.13
CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99
Control of innate immunity by memory CD4 T cells. Adv Exp Med Biol (2011) 0.88
Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection. Am J Transplant (2013) 0.82
Recurrence of autoimmunity in pancreas transplant patients: research update. Diabetes Manag (Lond) (2011) 0.81
IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditions. PLoS One (2010) 0.80
Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice. PLoS One (2014) 0.80
IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals. J Immunol (2014) 0.80
Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction. J Immunol (2013) 0.79
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection. J Neuroimmunol (2012) 0.77
Redirecting the immune response: role of adoptive T cell therapy. Hum Gene Ther (2010) 0.77
CD4 T Helper Cells Instruct Lymphopenia-Induced Memory-Like CD8 T Cells for Control of Acute LCMV Infection. Front Immunol (2016) 0.75
Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice. PLoS One (2015) 0.75
Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet. Immunology (2015) 0.75
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature (2003) 10.16
Defective CD8 T cell memory following acute infection without CD4 T cell help. Science (2003) 9.67
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol (2004) 6.80
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10
Maintaining the norm: T-cell homeostasis. Nat Rev Immunol (2002) 5.63
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell (2004) 5.59
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature (2006) 5.19
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS (2005) 5.08
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med (2000) 4.54
Cutting edge: naive T cells masquerading as memory cells. J Immunol (2000) 4.27
A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science (2002) 4.21
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med (1982) 3.34
Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A (1999) 3.06
CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol (1996) 3.02
The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol (2006) 2.96
Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity (1999) 2.89
HIV and autoimmunity. Autoimmun Rev (2002) 2.83
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med (1998) 2.72
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69
Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol (2002) 2.51
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 2.49
A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity (1994) 2.09
Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J Immunol (2005) 2.06
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83
Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo. J Immunol (2003) 1.62
A causal link between lymphopenia and autoimmunity. Immunol Lett (2004) 1.61
Organ-specific autoimmunity induced by lymphopenia. Immunol Rev (1996) 1.50
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes. J Exp Med (2000) 1.48
CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A (2008) 1.48
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells. J Immunol (2008) 1.38
T cell homeostasis and systemic autoimmunity. J Clin Invest (2001) 1.35
Memory CD8(+) T cells undergo peripheral tolerance. Immunity (2002) 1.16
The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol (2005) 1.12
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives. Springer Semin Immunopathol (2005) 0.89
Cross-presentation of antigens by dendritic cells. Crit Rev Immunol (2002) 0.89
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell (2008) 2.84
The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell (2003) 2.28
External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. Urology (2006) 2.05
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol (2004) 1.91
The association of body mass index and prostate-specific antigen in a population-based study. Cancer (2005) 1.85
ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J (2007) 1.68
Improving the performance of physiologic hot flash measures with support vector machines. Psychophysiology (2009) 1.54
Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol (2005) 1.50
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol (2008) 1.46
Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention. Eur Urol (2006) 1.43
Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev (2006) 1.33
IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood (2006) 1.26
Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007) 1.25
IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood (2002) 1.21
Assessment of 54 biomarkers for biopsy-detectable prostate cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.16
Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J Immunol (2003) 1.15
Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis. Proc Natl Acad Sci U S A (2005) 1.12
Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7. Urol Oncol (2008) 1.09
Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC. J Immunol (2003) 1.06
HTLV-1 tropism and envelope receptor. Oncogene (2005) 1.05
Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther (2010) 1.03
Support Vector Machines to improve physiologic hot flash measures: application to the ambulatory setting. Psychophysiology (2010) 1.02
The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood (2002) 1.02
Glut1-mediated glucose transport regulates HIV infection. Proc Natl Acad Sci U S A (2012) 1.02
The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood (2008) 0.98
Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology (2007) 0.96
Molecular and cellular basis of T cell lineage commitment. Semin Immunol (2010) 0.96
Erythroid glucose transporters. Curr Opin Hematol (2009) 0.95
IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J Immunol (2006) 0.95
Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients. Diabetes Care (2012) 0.94
In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer. J Clin Invest (2005) 0.92
A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy. PLoS Pathog (2010) 0.92
Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiency. Proc Natl Acad Sci U S A (2005) 0.91
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol (2013) 0.90
Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression. J Immunol (2013) 0.89
Intrathymic transplantation of bone marrow-derived progenitors provides long-term thymopoiesis. Blood (2009) 0.89
Combat urologic trauma in US military overseas contingency operations. J Trauma (2010) 0.89
Impaired anti-leukemic immune response in PKCtheta-deficient mice. Mol Immunol (2008) 0.89
A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity. Cancer Immunol Immunother (2003) 0.88
Lentiviral transduction of immune cells. Methods Mol Biol (2008) 0.86
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters. Lab Invest (2013) 0.86
Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells. Blood (2002) 0.85
T-cell receptor-induced phosphorylation of the zeta chain is efficiently promoted by ZAP-70 but not Syk. Blood (2004) 0.85
Molecularly imprinted chitosan-genipin hydrogels with recognition capacity toward o-xylene. Biomacromolecules (2007) 0.85
Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors. J Gene Med (2010) 0.84
Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells (2004) 0.84
Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Hum Pathol (2006) 0.83
Characterization of the surface structure of gold nanoparticles and nanorods using structure sensitive reactions. J Phys Chem B (2005) 0.83
Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology (2006) 0.82
Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL. Urology (2007) 0.82
HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection? Front Biosci (2004) 0.80
Intrathymic progenitor cell transplantation across histocompatibility barriers results in the persistence of early thymic progenitors and T-cell differentiation. Blood (2013) 0.80
Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates. Mol Ther (2008) 0.80
gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes. Blood (2002) 0.80
IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditions. PLoS One (2010) 0.80
Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice. J Virol (2007) 0.80
IL-7 and CD4+ T-cell proliferation. Blood (2002) 0.79
Metabolic pathways as regulators of HIV infection. Curr Opin HIV AIDS (2013) 0.79
Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement. J Immunol (2008) 0.78
The protooncogene Vav1 regulates murine leukemia virus-induced T-cell leukemogenesis. Oncoimmunology (2012) 0.77
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis. J Urol (2009) 0.77
An animal model of abdominal aortic aneurysm created with peritoneal patch: technique and initial results. Cardiovasc Intervent Radiol (2003) 0.77
Role of 5 alpha-reductase inhibitors in the management of prostate cancer. Clin Interv Aging (2006) 0.77
Optimal cost-effective staging evaluations in prostate cancer. Curr Urol Rep (2007) 0.77
Redirecting the immune response: role of adoptive T cell therapy. Hum Gene Ther (2010) 0.77
Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation. Curr Opin Hematol (2016) 0.76
Chemoprevention of prostate cancer with finasteride. Expert Opin Pharmacother (2006) 0.76
Biophone: Physiology monitoring from peripheral smartphone motions. Conf Proc IEEE Eng Med Biol Soc (2015) 0.76
Prostate cancer detection strategies. Curr Urol Rep (2006) 0.76
Ex vivo isolation protocols differentially affect the phenotype of human CD4+ T cells. J Immunol Methods (2002) 0.76
Concise review: hematopoietic stem cell transplantation: targeting the thymus. Stem Cells (2013) 0.76
External validation of a virtual reality transurethral resection of the prostate simulator. J Urol (2010) 0.76
Hematopoietic stem cell lineage specification. Curr Opin Hematol (2016) 0.76
The Global Thymus Network: past, present and future. Trends Immunol (2009) 0.76
In vivo and ex vivo gene transfer in thymocytes and thymocyte precursors. Methods Mol Biol (2009) 0.75
Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors. Cancer (2005) 0.75
Antibacterial activity of Sonoran propolis and some of its constituents against clinically significant Vibrio species. Foodborne Pathog Dis (2013) 0.75
Screening for prostate cancer: opportunities and challenges. Surg Oncol Clin N Am (2005) 0.75
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated? Curr Urol Rep (2005) 0.75
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Pancreas (2017) 0.75
What's new in the field of prostate cancer chemoprevention? Curr Oncol Rep (2004) 0.75
What's new in the field of prostate cancer chemoprevention? Curr Urol Rep (2005) 0.75
[GLUT-1 is the receptor of retrovirus HTLV]. Med Sci (Paris) (2004) 0.75
[Red cell GLUT1 compensates for the lack of vitamin C synthesis in mammals]. Med Sci (Paris) (2008) 0.75